With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Mechanisms to Redirect Tumor Associated Macrophages to Target Retinoblastoma Cells||The Regents of the University of Minnesota / Timothy Hallstrom, PhD||Innovation Grants||2023||Minnesota|
|Ex Vivo Modeling of Medulloblastoma using Human iPSC-Derived Cerebellar Organoids||St. Jude Children's Research Hospital / Stephanie Wu, PhD||Young Investigator Grants||2023||Tennessee|
|Targeting Chromatin Remodeling Complexes for Rhabdomyosarcoma (RMS) Therapy||Dana-Farber Cancer Institute / Jun Qi, PhD||Innovation Grants||2023||Massachusetts|
|Targeting Neurons in the Osteosarcoma Microenvironment with Non-Opioid Analgesic Lipid Nanoparticles||The Johns Hopkins University School of Medicine / Aaron James, MD, PhD||Innovation Grants||2023||Maryland|
|Targeting the Checkpoint Receptor TIGIT via CRISPR/Cas9 Genome Editing to Enhance NK Cell Anti-Tumor Activity||Research Institute at Nationwide Children's Hospital / Amanda Campbell, MD/PhD||Young Investigator Grants||2023||Ohio|
|Mechanisms of BRAF Activation in KIAA1549-BRAF Mutant pLGGs||Broad Institute / Sean Misek, PhD||Young Investigator Grants||2023||Massachusetts|
|Epigenetic Enhancement of MHCI to Augment Neuroblastoma Immunotherapy||University of Wisconsin - Madison / Paul Sondel, MD, PhD and Amy Erbe-Gurel, PhD||Innovation Grants||2022||Wisconsin|
|Blocking the Evil Messenger in MYCN-driven High-risk Neuroblastoma||Boston University / Hui Feng, Md, PhD||Innovation Grants||2022||Massachusetts|
|Impact of STAG2 loss on DNA Damage and Immunobiology in Ewing sarcoma||University of Pittsburgh / Kelly Bailey, MD, PhD||Innovation Grants||2022||Pennsylvania|
|Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants||University of Washington, Seattle / Abbye McEwen, MD, PhD||RUNX1 Early Career Investigator Grants||2022||Washington|